GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » Debt-to-Equity

Lumiera Health (TSXV:NHP.H) Debt-to-Equity : -0.78 (As of Aug. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health Debt-to-Equity?

Lumiera Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.93 Mil. Lumiera Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.39 Mil. Lumiera Health's Total Stockholders Equity for the quarter that ended in Aug. 2023 was C$-1.69 Mil. Lumiera Health's debt to equity for the quarter that ended in Aug. 2023 was -0.78.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Lumiera Health's Debt-to-Equity or its related term are showing as below:

TSXV:NHP.H' s Debt-to-Equity Range Over the Past 10 Years
Min: -11.32   Med: -0.71   Max: 6.11
Current: -0.78

During the past 10 years, the highest Debt-to-Equity Ratio of Lumiera Health was 6.11. The lowest was -11.32. And the median was -0.71.

TSXV:NHP.H's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.3 vs TSXV:NHP.H: -0.78

Lumiera Health Debt-to-Equity Historical Data

The historical data trend for Lumiera Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumiera Health Debt-to-Equity Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 -0.64 -9.43 1.88 -0.94

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.68 -0.94 -0.98 -0.98 -0.78

Competitive Comparison of Lumiera Health's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumiera Health's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Lumiera Health's Debt-to-Equity falls into.



Lumiera Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Lumiera Health's Debt to Equity Ratio for the fiscal year that ended in Nov. 2022 is calculated as

Lumiera Health's Debt to Equity Ratio for the quarter that ended in Aug. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumiera Health  (TSXV:NHP.H) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Lumiera Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Lumiera Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumiera Health (TSXV:NHP.H) Business Description

Traded in Other Exchanges
N/A
Address
4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health (TSXV:NHP.H) Headlines

No Headlines